Explain and Monitor Deep Learning Models for Computer Vision using Obz AI

Deep learning has transformed computer vision (CV), achieving outstanding performance in classification, segmentation, and related tasks. Such AI-based CV systems are becoming prevalent, with applications spanning from medical imaging to surveillance. State of the art models such as convolutional neural networks (CNNs) and vision transformers (ViTs) are often regarded as ``black boxes,'' offering limited transparency into their decision-making processes. Despite a recent advancement in explainable AI (XAI), explainability remains underutilized in practical CV deployments. A primary obstacle is the absence of integrated software solutions that connect XAI techniques with robust knowledge management and monitoring frameworks. To close this gap, we have developed Obz AI, a comprehensive software ecosystem designed to facilitate state-of-the-art explainability and observability for vision AI systems. Obz AI provides a seamless integration pipeline, from a Python client library to a full-stack analytics dashboard. With Obz AI, a machine learning engineer can easily incorporate advanced XAI methodologies, extract and analyze features for outlier detection, and continuously monitor AI models in real time. By making the decision-making mechanisms of deep models interpretable, Obz AI promotes observability and responsible deployment of computer vision systems.

Safeguarding Generative AI Applications in Preclinical Imaging through Hybrid Anomaly Detection

Generative AI holds great potentials to automate and enhance data synthesis in nuclear medicine. However, the high-stakes nature of biomedical imaging necessitates robust mechanisms to detect and manage unexpected or erroneous model behavior. We introduce development and implementation of a hybrid anomaly detection framework to safeguard GenAI models in BIOEMTECH's eyes(TM) systems. Two applications are demonstrated: Pose2Xray, which generates synthetic X-rays from photographic mouse images, and DosimetrEYE, which estimates 3D radiation dose maps from 2D SPECT/CT scans. In both cases, our outlier detection (OD) enhances reliability, reduces manual oversight, and supports real-time quality control. This approach strengthens the industrial viability of GenAI in preclinical settings by increasing robustness, scalability, and regulatory compliance.